FDA review and approval is by NO means "technicalities." It is all that counts as the FDA determines commercial availability or not. The require a well-controlled clinical trial for providing proper evidence. Unfortunately the NWBO trial does not meet the requirements after they tossed out the failed primary endpoint and changed everything in the trial -- new protocol, endpoints, comparator and SAP.
Market Data 
Markets 
AI
